IL6 and cancer: Recent studies have highlighted the potential of CNTO328, a chimeric murine anti-human IL6 antibody, to neutralize the function of IL6 and reduce the incidence of cancer-related anorexia and cachexia without serious adverse effects (Table 2) [100].